Matthew Scholz
Chief Executive Officer
Oisin BioTechnologiesSeattle, Washington, United States
3 investmentsMatthew Scholz is a Chief Executive Officer at Oisin BioTechnologies based in Seattle, Washington, United States. Matthew Scholz has backed 3 companies, including Immusoft, Oisin BioTechnologies and Point B Telematics. Investment focus areas include Android, Software and Biotechnology.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (3)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Immusoft | — | — | — | — |
| 2 | Oisin BioTechnologies | — | — | — | — |
| 3 | Point B Telematics | — | — | — | — |
Showing 1–3 of 3
Access Full Contact Information
Get Matthew Scholz's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required